By Momo Yamamoto, Senior Investor Research Analyst, LSN
RESI JPM brings together early-stage life science innovators and active investors during one of the industry’s most important weeks, and Life Science Nation is pleased to announce the investor judges participating in the Innovator’s Pitch Challenge (IPC).
This year’s IPC will feature more than 90 presenting companies across 24 pitch sessions over two days, offering startups a high-impact opportunity to gain visibility, pitch directly to investors, and receive real-time feedback from experienced decision-makers.
Each pitch session will be evaluated by a panel of investor and strategic partner judges with expertise spanning therapeutics, medical devices, diagnostics, digital health, and life science tools. Following every presentation, judges will lead a live Q&A to assess the opportunity and share perspective on scientific differentiation, commercial potential, and investment readiness.
All IPC companies will also be assigned a dedicated space in the RESI Exhibition Hall, creating additional opportunities for follow-up conversations and deeper engagement with investors and conference attendees.
In addition, RESI JPM attendees will be invited to vote with their RESI Cash for their favorite presenting companies. The Top 3 companies will be announced during the conference reception. Winners will receive a prize and be featured in an upcoming issue of the LSN newsletter, reaching a global audience of investors and life science innovators.
Scroll down to see which investors will serve as judges for this year’s RESI JPM Innovator’s Pitch Challenge.
 Smriti Agrawal TiE Angels |
 Chris Aleong BioIdeations |
 Ibraheem Alinur 2Flo Ventures |
 Jolene Anderson VectorPoint Ventures |
 Ali Ardakani Novateur Ventures Inc. |
 Dylan Attard Ikigai Ventures |
 Zachary Betts Zandia Ventures |
 Kumar Bhargava PharmaCatalyst |
 Benjamin Chen Panacea Venture |
 Jenna Chow HKSTP Venture Fund |
 Michael Christensen Prometheus Medical Ventures |
 Bruce Cohen Xeraya Capital |
 Pat Cooke Merck Digital Sciences Studio |
 Anne Degheest HealthTech Capital |
 Yizhen Dong Raise Health |
 Karen Drexler Astia Fund |
 Linda Elkins W47 Angels |
 Bettina Ernst BERNINA BioInvest |
 Idong Essiet-Gibson She’s Independent |
 Larry Florin Eckuity Capital |
 Karim Galzahr OKG Capital |
 Dimitra Georganopoulou Qral Ventures |
 Gary Gershony BayMed Venture Partners |
 Lucien Ghislain Life Science Angels |
 Kristin Gleitsman Fellows Fund VC |
 Navin Govind Evidence Ventures |
 Joe Hanssen Osterbury Capital |
 Isaac Haq HINA Bioventures |
 Lindsay Hoover JLS Fund |
 Elena Itskovich Nest Catalyst |
 Sherry Jiang Genertec America,Inc |
 Jacob Johnson Laerdal Million Lives Fund |
 Mo Kagalwala NuFund Venture Group |
 David Katz Angel Investor |
 Danil Kislinskiy GGW Ventures (Go Global World) |
 Maria Kondratyev Phoenix Gate Ventures |
 Matthew Konneh Atheneos Ventures |
 Rebecca Lin Stanford Angels and Entrepreneurs |
 Ken Lin ABIES Capital |
 Karen Liu 3E Bioventures |
 Wojciech Majewski Global Health Impact Fund |
 Nune Martiros Paladin Capital Group |
 Dana Matzen CTI Life Sciences Fund |
 Ray Minato INERTIA Product Development |
 James Murray ExSight Ventures |
 Naoki Nagakura Teikoku Ventures, Inc. (TVI) |
 Pejman Naraghi-Arani Biomedical Advanced R&D Authority (BARDA) |
 Ken Nelson Medtech Advantage Fund |
 Tam Nguyen Horizon 3 Biotech |
 Andrew Offer Scientific Health Development Partners (SHD) |
 Ying Ou Life Science Angels |
 John Pennett Mid Atlantic Bio Angels |
 Leonard Pickard JLS Fund |
 Pablo Prieto CG Health Ventures |
 Bikash Rajkarnikar Haleon |
 Reza Sabahi Tellaro Capital Partners |
 Julie Schafer Flu Lab |
 Roman Schenk INOGROUP |
 Laly Scherf I-Next Capital |
 Jordan Schultz Pacific Bridge NY |
 Claire Smith Springtide Investments |
 Zane Starkewolfe WuXi Biologics Healthcares Venture |
 Eran Steinberg Imaging Arts |
 Stephanie Steltzer University of Michigan – Michigan Biomedical Venture Fund |
 Timothy Sung Esplanade HealthTech Ventures |
 Prasad Sunkara Seed to Fruit Fund |
 Mark Tang Good Health Capital |
 Kristin Thompson Mérieux Equity Partners |
 Guillaume Thoviste Mérieux Equity Partners |
 Paola Torre Life Science Angels |
 Megha Unhelkar Connecticut Innovations |
 Santhosh Vadivelu AdimaBio |
 Tom Vogelsong K2X Capital |
 Nicole Wang Intuitive Surgical |
 Sally Wang Liang Xpanse Venture |
 Robert Warren Hamamatsu Ventures |
 Jason Weshler Siemens Healthineers |
 Jim Wu SaniMed Science Group |
 Wei Xiao Lipos Healthcare Investment |
 Jun Xiao Life Science Angels |
 Deborah Zajac SOSV |
 Rosanna Zhang Coho Deeptech |
 Adam (Chunlin) Zhao Anlong Medical Fund |
 Don Zinn Crossject |
| Register for RESI JPM 2026 |
Next Phase Newsletter 
Leave a comment